1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth
- 1 August 1981
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 101 (4), 1131-1138
- https://doi.org/10.1016/0006-291x(81)91565-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- Chemical synthesis of [1β-3H]1α,25-dihydroxyvitamin D3 and [1α-3H]1β,25-dihydroxyvitamin D3: Biological activity of 1β,25-dihydroxyvitamin D3Biochemical and Biophysical Research Communications, 1980
- Specific binding of 1,25 dihydroxyvitamin D3 in the VX2 carcinomaBiochemical and Biophysical Research Communications, 1980
- Vitamin D in lactation I. The localization, specific binding and biological effect of 1, 25-dihydroxyvitamin D3 in mammary tissue of lactating ratsLife Sciences, 1980
- NORMAL AND MALIGNANT BREAST TISSUE IS A TARGET ORGAN FOR 1, 25‐(OH)2 VITAMIN D3Clinical Endocrinology, 1980
- Biochemical properties of 1α,25-dihydroxyvitamin D receptorsJournal of Steroid Biochemistry, 1980
- Basic and Clinical Concepts Related to Vitamin D Metabolism and ActionNew England Journal of Medicine, 1977
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956